Antibodies & Hybridomas — page 211 of 1,868
Antibodies & Hybridomas
Page 211 of 1,868
| Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
|---|---|---|---|---|---|---|---|---|
| CCNT1 | monoclonal | Recombinant Rabbit | human, mouse, rat | unconjugated | n/a | n/a |
 CREATIVE BIOLABS, INC. |
More Info |
| CCNT2 | monoclonal | Recombinant Mouse | human | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| CCoV NP | monoclonal | Recombinant Mouse | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| CCP | monoclonal | Recombinant Human | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| CCP | monoclonal | Recombinant Human | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| CCP | monoclonal | Recombinant Human | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| CCP | monoclonal | Recombinant Human | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| CCP | monoclonal | Recombinant Human | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| CCP (Cyclic citrullinated peptide) | monoclonal | Recombinant Human | human | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| CCR3 | 5E8-G9-B4 | Recombinant Mouse | human | unconjugated | 200 µg | n/a |
 ORIGENE TECHNOLOGIES |
More Info |
| CCR3 | 5E8-G9-B4 | Recombinant Rabbit | human | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| CCR4 | KW-0761 (Mogamulizumab) | Recombinant Mouse | human | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| CCR4 | KW-0761 (Mogamulizumab) | Recombinant Rabbit | human | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| CCR5 | E11/19 | Recombinant Mouse | human | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| CCR5 | E11/19 | Recombinant Rabbit | human | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| CCR5 | RC-10 | Recombinant Mouse | human | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| CCR5 | RC-10 | Recombinant Rabbit | human | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| CCR5 | T21/8 | Recombinant Mouse | human | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| CCR5 | T21/8 | Recombinant Rabbit | human | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| CCR5 | V14/2 | Recombinant Mouse | human | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| CCR5 | V14/2 | Recombinant Rabbit | human | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| Ccr7 | 4B12 | Recombinant Rabbit | mouse | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| Ccr7 | 4B12 | Recombinant Rat | mouse | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| Ccr9 | 9B1 | Recombinant Rabbit | mouse | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| Ccr9 | 9B1 | Recombinant Rat | mouse | unconjugated | 200 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
| CCR2 | 4.9 | Recombinant Rabbit | human | purified | 200 µg | n/a |
 ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR2 | MLN1202 (Plozalizumab, hu1D9) | Recombinant Rabbit | human | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR2 | 4.9 | Recombinant Human | human | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR2 | 4.9 | Recombinant Human | human | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR2 | MLN1202 (Plozalizumab, hu1D9) | Recombinant Human | human | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR2 | MLN1202 (Plozalizumab, hu1D9) | Recombinant Human | human | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR2 | 4.9 | Recombinant Mouse | human | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR2 | 4.9 | Recombinant Mouse | human | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR2 | MLN1202 (Plozalizumab, hu1D9) | Recombinant Mouse | human | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR2 | MLN1202 (Plozalizumab, hu1D9) | Recombinant Mouse | human | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR2 | AbAb-CCR2 | Recombinant Rabbit | mouse | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR2 | AbAb-CCR2 | Recombinant Mouse | mouse | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR2 | AbAb-CCR2 | Recombinant Mouse | mouse | purified | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR2 | AbAb-CCR2 | Recombinant Rat | mouse | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR2 | AbAb-CCR2 | Recombinant Rat | mouse | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR4 | KW-0761 (Mogamulizumab) | Recombinant Rabbit | human | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR4 | KW-0761 (Mogamulizumab) | Recombinant Mouse | human | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR5 | ST6 | Recombinant Rabbit | human, rhesus macaque | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR5 | ST6 | Recombinant Mouse | human, rhesus macaque | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR5 | ST6 | Recombinant Human | human, rhesus macaque | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR5 | T21/8 | Recombinant Rabbit | human | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR5 | T21/8 | Recombinant Human | human | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR5 | T21/8 | Recombinant Human | human | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR5 | T21/8 | Recombinant Mouse | human | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
| CCR5 | T21/8 | Recombinant Mouse | human | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |